Amgen Inc (NASDAQ:AMGN)

172.93
Delayed Data
As of Apr 19
 -2.18 / -1.24%
Today’s Change
152.16
Today|||52-Week Range
201.23
-0.56%
Year-to-Date

Today’s Trading

Previous close175.11
Today’s open174.47
Day’s range171.79 - 175.40
Volume2,269,424
Average volume (3 months)4,440,876
Market cap$137.7B
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)-73.73%
Earnings growth (this year)+6.60%
Earnings growth (next 5 years)+5.49%
Revenue growth (last year)+0.45%
P/E ratio64.3
Price/Sales5.61
Price/Book5.47

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-1.24-1.64%
BIIBBiogen-2.01-0.75%
ILMNIllumina Inc-4.16-1.66%
----
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateApril 24, 2018
EPS forecast (this quarter)$3.20
Annual revenue (last year)$22.8B
Annual profit (last year)$2.0B
Net profit margin8.69%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts